Mar 8 |
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress
|
Mar 6 |
Applied Therapeutics: Q4 Earnings Insights
|
Mar 6 |
Applied Therapeutics GAAP EPS of -$1.42 beats by $0.02, revenue of $10M misses by $0.67M
|
Mar 6 |
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
|
Feb 28 |
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Feb 28 |
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
|
Feb 28 |
Applied Therapeutics up 51% pre-market after announcing $100M equity raise
|
Feb 28 |
Applied Therapeutics Announces $100 Million Private Placement
|
Feb 28 |
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
|
Feb 21 |
13 Best Booming Stocks to Buy Right Now
|